Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News What’s driving GH Research’s stock spike? FDA IND verdict looms for lead depression candidate GH Research is set to update investors on its FDA IND filing and Phase 3 launch plans for GH001. Find out what this means for its future in depression treatment. byPallavi MadhirajuJanuary 3, 2026